Bojan Vilagos

941 total citations
8 papers, 425 citations indexed

About

Bojan Vilagos is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Bojan Vilagos has authored 8 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Bojan Vilagos's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Bojan Vilagos is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Bojan Vilagos collaborates with scholars based in Austria, Switzerland and Germany. Bojan Vilagos's co-authors include Meinrad Busslinger, Markus Jaritz, Ivan Bilić, Hiromi Tagoh, Leonie Smeenk, Andreas Sommer, Roger Revilla‐i‐Domingo, Ido Tamir, Anja Ebert and Jasna Medvedovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Bojan Vilagos

8 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bojan Vilagos Austria 7 247 164 60 53 50 8 425
Ryuji Iida United States 9 320 1.3× 120 0.7× 56 0.9× 20 0.4× 72 1.4× 13 460
Hila Shaim United States 10 222 0.9× 73 0.4× 131 2.2× 24 0.5× 80 1.6× 19 360
Yong‐Min Lin China 13 167 0.7× 155 0.9× 77 1.3× 20 0.4× 62 1.2× 24 389
L. Alexander Liggett United States 7 110 0.4× 193 1.2× 32 0.5× 133 2.5× 79 1.6× 7 446
Michael Chiorazzi United States 7 113 0.5× 132 0.8× 56 0.9× 25 0.5× 33 0.7× 13 287
Akinola Olumide Emmanuel United States 7 191 0.8× 163 1.0× 86 1.4× 28 0.5× 16 0.3× 11 365
John R. Seavitt United States 7 137 0.6× 231 1.4× 43 0.7× 83 1.6× 54 1.1× 10 380
Ivan Sloma France 12 169 0.7× 104 0.6× 60 1.0× 30 0.6× 221 4.4× 30 423
Pietro Miozzo United States 8 254 1.0× 104 0.6× 50 0.8× 18 0.3× 9 0.2× 11 370
Baranda S. Hansen United States 9 86 0.3× 123 0.8× 25 0.4× 16 0.3× 26 0.5× 20 240

Countries citing papers authored by Bojan Vilagos

Since Specialization
Citations

This map shows the geographic impact of Bojan Vilagos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojan Vilagos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojan Vilagos more than expected).

Fields of papers citing papers by Bojan Vilagos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojan Vilagos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojan Vilagos. The network helps show where Bojan Vilagos may publish in the future.

Co-authorship network of co-authors of Bojan Vilagos

This figure shows the co-authorship network connecting the top 25 collaborators of Bojan Vilagos. A scholar is included among the top collaborators of Bojan Vilagos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojan Vilagos. Bojan Vilagos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hagelkrüys, Astrid, Gerald Wirnsberger, Johannes Stadlmann, et al.. (2020). A crucial role for Jagunal homolog 1 in humoral immunity and antibody glycosylation in mice and humans. The Journal of Experimental Medicine. 218(1). 15 indexed citations
3.
Khamina, Kseniya, Alexander Lercher, Michael Caldera, et al.. (2017). Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein. PLoS Pathogens. 13(12). e1006758–e1006758. 15 indexed citations
4.
Kreslavsky, Taras, Bojan Vilagos, Hiromi Tagoh, et al.. (2017). Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells. Nature Immunology. 18(4). 442–455. 79 indexed citations
5.
Kosack, Lindsay, Riem Gawish, Alexander Lercher, et al.. (2017). The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis. Scientific Reports. 7(1). 11289–11289. 10 indexed citations
6.
Revilla‐i‐Domingo, Roger, Ivan Bilić, Bojan Vilagos, et al.. (2012). The B‐cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. The EMBO Journal. 31(14). 3130–3146. 161 indexed citations
7.
Vilagos, Bojan, Mareike D. Hoffmann, Abdallah Souabni, et al.. (2012). Essential role of EBF1 in the generation and function of distinct mature B cell types. The Journal of Experimental Medicine. 209(4). 775–792. 97 indexed citations
8.
Johnson, Burles A., David J. Kahler, Babak Baban, et al.. (2010). B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proceedings of the National Academy of Sciences. 107(23). 10644–10648. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026